NAT10 and cancer: Furthermore, in two (ACC and HNSC) of the above five types of cancer, NAT10 expression showed a significant positive correlation with tumor purity in TIMER2 and a significant correlation with prognosis in GEPIA2, whereas KIRP, LIHC, and PCPG had no correlation of NAT10 with tumor purity in TIMER2.